Immediate Impact

2 by Nobel laureates 8 from Science/Nature 71 standout
Sub-graph 1 of 18

Citing Papers

Polymeric Nanoparticles for Drug Delivery
2024 Standout
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
2023 Standout
4 intermediate papers

Works of Mark Keegan being referenced

Development and preclinical evaluation of SEL-068, a novel targeted Synthetic Vaccine Particle ( t SVP™) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine (75.11)
2012
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange
2005

Author Peers

Author Last Decade Papers Cites
Mark Keegan 609 513 139 229 11 1.0k
M.A.A. van Walderveen 1157 442 182 97 9 1.4k
S Jaakkola 154 219 346 96 24 1.3k
Becky Parks 664 338 168 314 30 1.1k
Josephine Swanton 1195 607 116 89 21 1.4k
Amy Pace 966 535 103 242 15 1.2k
J. Deans 607 298 108 269 10 978
Lisa Costelloe 478 133 98 478 15 989
Qingyun Tian 71 312 442 132 23 1.1k
B. G. Weinshenker 715 581 183 225 16 1.1k
Elena Charro Huerga 982 447 103 30 22 1.2k

All Works

Loading papers...

Rankless by CCL
2026